In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2

Molecular Endocrinology

Volumn 24, Issue 1, 2010, Pages 204-217

  Barclay, Johanna L ^a   Kerr, Linda M ^a   Arthur, Leela ^a   Rowland, Jennifer E ^a,b   Nelson, Caroline N ^a   Ishikawa, Mayumi ^c   D'Aniello, Elisabetta M ^a   White, Mary ^a   Noakes, Peter G ^a   Waters, Michael J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; LIVER ENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SOMATOMEDIN BINDING PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; STEROID RECEPTOR COACTIVATOR 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; IN VIVO STUDY; LEG LENGTHENING; MALE; MOUSE; MOUSE STRAIN; MUTANT; NONHUMAN; OBESITY; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF;

AGING; ANIMALS; BODY WEIGHTS AND MEASURES; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION PROFILING; GENE KNOCK-IN TECHNIQUES; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; JANUS KINASE 2; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, SOMATOTROPIN; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT TRANSCRIPTION FACTORS;

MUS;

EID: 73549121928     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0233     Document Type: Article

References (43)

1. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C 1993 Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244
2. Frank SJ, Gilliland G, Kraft AS, Arnold CS 1994 Interaction of the GH receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135:2228-2239
3. Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA, Brown RJ 2006 New insights into growth hormone action. J Mol Endocrinol 36:1-7
4. Smit L, Meyer D, Argetsinger L, Schwartz J, Carter-Su C 1999 Molecular events in GH-receptor interaction and signaling. In: Kostyo JL, ed. Handbook of physiology, section 7: the endocrine system. New York: Oxford University Press; 445-480
5. Clayton PE, Freeth JS, Whatmore AJ, Ayling RM, Norman MR, Silva CM 1999 Signal transduction defects in growth hormone insensitivity. Acta Paediatr Suppl 88:174 -178; discussion 179
6. Zhu T, Ling L, Lobie PE 2002 Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent. J Biol Chem 277:45592-45603
7. Rowlinson SW, Yoshizato H, Barclay JL, Brooks AJ, Behncken SN, Kerr LM, Millard K, Palethorpe K, Nielsen K, Clyde-Smith J, Hancock JF, Waters MJ 2008 An agonist-induced conformational change in the growth hormone receptor determines the choice of signaling pathway. Nat Cell Biol 10:740-747
8. Fresno Vara JA, Carretero MV, Gerónimo H, Ballmer-Hofer K, Martín-Pérez J 2000 Stimulation of c-Src by prolactin is independent of Jak2. Biochem J 345:17-24
9. Arai A, Kanda E, Nosaka Y, Miyasaka N, Miura O 2001 CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling. J Biol Chem 276:33282-33290
10. Rowland JE, Kerr LM, White M, Noakes PG, Waters MJ 2005 Heterozygote effects in mice with partial truncations in the growth hormone receptor cytoplasmic domain: assessment of growth parameters and phenotype. Endocrinology 146:5278-5286
11. Rowland JE, Lichanska AM, Kerr LM, White M, d'Aniello EM, Maher SL, Brown R, Teasdale RD, Noakes PG, Waters MJ 2005 In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol 25:66-77
12. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/ binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220
13. Choi HK, Waxman DJ 2000 Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology 141:3245-3255
14. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R 1998 STAT3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18:2545-2552
15. Thompson BJ, Shang CA, Waters MJ 2000 Identification of genes induced by GH in rat liver using cDNA arrays. Endocrinology 141: 4321-4324
16. Clodfelter KH, Holloway MG, Hodor P, Park SH, Ray WJ, Waxman DJ 2006 Sex-dependent liver gene expression is extensive and largely dependent on STAT5b: STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20:1333-1351
17. Engblom D, Kornfeld JW, Schwake L, Tronche F, Reimann A, Beug H, Hennighausen L, Moriggl R, Schütz G 2007 Direct glucocorticoid receptor-STAT5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev 21:1157-1162
18. Holloway MG, Cui Y, Laz EV, Hosui A, Hennighausen L, Waxman DJ 2007 Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology 148:1977-1986
19. Goodyer CG, Rhani Z, Zheng H 2008 Expression of the hepatic specific V1 messenger ribonucleic acid of the human growth hormone receptor gene is regulated by hepatic nuclear factor (HNF)-4α2 and HNF-4α8. Mol Endocrinol 2008 22:485-500
20. Xu Q, Walther N, Jiang H 2004 Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and hepatocyte nuclear factor 4γ(HNF-4γ) and HNF-4αregulate the bovine growth hormone receptor 1A promoter through a common DNA element. J Mol Endocrinol 32:947-961
21. Yoon S, Seger R 2006 The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44
22. Cakmakci NG, Lerner RS, Wagner EJ, Zheng L, Marzluff WF 2008 SLIP1, a factor required for activation of histonemRNAtranslation by the stem-loop binding protein. Mol Cell Biol 28:1182-1194
23. Yu R, Melmed S 2004 Pituitary tumor transforming gene: an update. Front Horm Res 32:175-185
24. Rosenfeld RG, Belgorosky A, Camacho-Hubner C, Savage MO, Wit JM, Hwa V 2007 Defects in growth hormone receptor signaling. Trends Endocrinol Metab 18:134-141
25. Tiulpakov A, Rubtsov P, Dedov I, Peterkova V, Bezlepkina O, Chrousos GP, Hochberg Z 2005 A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. J Clin Endocrinol Metab 90:542-547
26. Chia DJ, Ono M, Woelfle J, Schlesinger-Massart M, Jiang H, Rotwein P 2006 Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J Biol Chem 281:3190-3197
27. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162
28. Hogan JC, Stephens JM 2005 The regulation of fatty acid synthase by STAT5A. Diabetes 54:1968-1975
29. White UA, Coulter AA, Miles TK, Stephens JM 2007 The STAT5A-mediated induction of pyruvate dehydrogenase kinase 4 expression by prolactin or growth hormone in adipocytes. Diabetes 56:1623-1629
30. Fain JN, Ihle JN, Bahouth SW 1999 Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice. Biochem Biophys Res Commun 263:201-205
31. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW 1997 Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94:7239-7244
32. Jin H, Lanning NJ, Carter-Su C 2008 JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells. Mol Endocrinol 22:1825-1841
33. Choi JH, Kim HS, Kim SH, Yang YR, Bae YS, Chang JS, Kwon HM, Ryu SH, Suh PG 2006 Phospholipase Cγ1 negatively regulates GH signaling by forming a ternary complex with JAK2 and protein tyrosine phosphatase-1B. Nat Cell Biol 8:1389-1397
34. Hosui A, Hennighausen L 2008 Genomic dissection of the cytokine-controlled STAT5 signaling network in liver. Physiol Genomics 34:135-143
35. Lichanska AM, Waters MJ 2008 How GH controls growth, obesity and sexual dimorphism. Trends Genet 24:41-47
36. Vigneron A, Roninson IB, Gamelin E, Coqueret O 2005 Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. Cancer Res 65:8927-8935
37. Gregory PA, Gardner-Stephen DA, Lewinsky RH, Duncliffe KN, Mackenzie PI 2003 Cloning and characterization of the human UDP- glucuronosyltransferase 1A8, 1A9 and 1A10 gene promoters: differential regulation through an interior-like region. J Biol Chem 278:3601-3614
38. Hirano K, Min J, Funahashi T, Davidson NO 1997 Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in the mouse and rat. J Lipid Res 38:1103-1119
39. Acosta JJ, Muñoz RM, González L, Subtil-Rodríguez A, Dominguez-Caceres MA, García-Martínez JM, Calcabrini A, Lazaro-Trueba I, Martín-Pérez J 2003 Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/ Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol Endocrinol 17:2268-2282
40. Wu H, Liu X, Jaenisch R 1994 Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 91:2819-2823
41. Sambrook J, Fritsch E, Maniatis T 1989 Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
42. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143
43. Lobie PE, Wood TJ, Chen CM, Waters MJ, Norstedt G 1994 Nuclear translocation and anchorage of the GH receptor. J Biol Chem 269:31735-31746